TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15705990

Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroids (ICSs)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control subjects (no ICS treatment)
Number of subjects: 27
Study: 14504146

Group type: EXPERIMENTAL
Intervention: ECG guidance with a Seldinger guide wire (ID-A)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: ECG guidance with saline 10% used as an exploring electrode (ID-B)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Catheter rotation and advancement until all three lumina could be aspirated easily (ID-C)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Post-procedural chest X-ray (CXR)
Number of subjects: 114
Study: 10372700

Group type: EXPERIMENTAL
Intervention: Medroxyprogesterone acetate (MPA; 5 mg/day)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Estrogen plus MPA (0.625 mg/day conjugated equine estrogen and 5 mg/day MPA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Estrogen alone
Number of subjects: 0
Study: 8675938

Group type: EXPERIMENTAL
Intervention: Geriatric evaluation and management (GEM)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Usual primary care (UPC)
Number of subjects: 160
Study: 1801057

Group type: EXPERIMENTAL
Intervention: Conventional low protein diet (0.6 g/kg/day protein, 800 mg phosphate; n = 33)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Low phosphate diet (providing approximately 1000 mg phosphate plus an orally administered phosphate binder, minimum protein intake 0.8 g/kg/day; n = 30)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Control (minimum protein intake 0.8 g/kg/day, no phosphate restriction; n = 32)
Number of subjects: 95
Study: 6859212

Group type: EXPERIMENTAL
Intervention: Monofocal convex lenses (+1.25 D over far Rx)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Bifocals (+1.5 D near adds)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Sham treatment (no. 1 pink tint)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Monofocal treatment
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Bifocal treatment
Number of subjects: 120
Study: 30904839

Group type: EXPERIMENTAL
Intervention: Twice a week programme (n=20)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Once a week programme (n=20)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Wait-list control group (n=20)
Number of subjects: 60
Study: 28166914

Group type: EXPERIMENTAL
Intervention: Anti-tubercular therapy (ATT) for 6 months
Number of subjects: 100

Group type: COMPARATOR
Intervention: No anti-tubercular therapy (no ATT)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: ATT
Number of subjects: 100
Study: 27016906

Group type: EXPERIMENTAL
Intervention: Conservative Treatment (CT), n = 42
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Surgical Treatment (ST), n = 42
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Conservative Treatment (CT), n = 41 (after follow-up)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Surgical Treatment (ST), n = 40 (after follow-up)
Number of subjects: 84
Study: 25124998

Group type: EXPERIMENTAL
Intervention: miR-323-3p
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: miR-652
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: miR-27b
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: miR-323-3p and miR-652
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: miR-103
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: miR-208a
Number of subjects: 200
Study: 22080631

Group type: EXPERIMENTAL
Intervention: In-home cognitive, physical, and functional rehabilitation over a 3-month period via a social worker or master's level psychology technician utilizing telemedicine
Number of subjects: 21

Group type: COMPARATOR
Intervention: Usual care (sporadic rehabilitation)
Number of subjects: 21
Study: 19183094

Group type: EXPERIMENTAL
Intervention: Information framing emphasizing cervical cancer protection
Number of subjects: 635

Group type: COMPARATOR
Intervention: Alternate versions of the descriptive paragraph
Number of subjects: 635
Study: 17546496

Group type: EXPERIMENTAL
Intervention: Immediate rental housing assistance
Number of subjects: 630

Group type: COMPARATOR
Intervention: Assistance finding housing according to local standard practice
Number of subjects: 630
Study: 15102635

Group type: EXPERIMENTAL
Intervention: Standard postural drainage chest physiotherapy (SPT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Modified physiotherapy regimen (MPT) without head-down tilt
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Non-nutritive sucking during SPT
Number of subjects: 20
Study: 11772148

Group type: EXPERIMENTAL
Intervention: Indapamide sustained-release (SR) 1.5 mg/day
Number of subjects: 1195
Study: 9090347

Group type: EXPERIMENTAL
Intervention: dl-fenfluramine
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 7948822

Group type: EXPERIMENTAL
Intervention: Endoscopic biliary drainage (group Ia)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Surgery (group Ib)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Endoscopic biliary drainage and surgery (both groups)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Deterioration of T lymphocyte function
Number of subjects: 59

Group type: COMPARATOR
Intervention: T lymphocyte function
Number of subjects: 59
Study: 3365665

Group type: EXPERIMENTAL
Intervention: High-dose metoclopramide (8 mg/kg)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Low-dose metoclopramide (0.8 mg/kg)
Number of subjects: 46
Study: 30711879

Group type: EXPERIMENTAL
Intervention: Static balance
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Muscle strength of knee extensors, knee flexors, plantarflexors, and dorsiflexors
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Functional balance (Mini-BESTest)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Multivariate regression models including postural sway, muscle strength, age, and gender
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Postural sway
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Muscle strength
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Balance
Number of subjects: 90
Study: 27873046

Group type: EXPERIMENTAL
Intervention: Web-based lifestyle modification program (Precision Nutrition Coaching)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 35
Study: 26934167

Group type: EXPERIMENTAL
Intervention: ZEEP (zero end-expiratory pressure) group
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: PEEP (8 cm H2O positive end-expiratory pressure) group
Number of subjects: 27
Study: 24376273

Group type: EXPERIMENTAL
Intervention: Parenteral artesunate
Number of subjects: 72
Study: 21960669

Group type: EXPERIMENTAL
Intervention: Intravenous peramivir (600 mg)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Oral oseltamivir (75 mg)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Oral rimantadine (100 mg)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Combination of peramivir with oseltamivir or rimantadine
Number of subjects: 21
Study: 19046761

Group type: EXPERIMENTAL
Intervention: 5-grass-pollen sublingual immunotherapy tablets (300 IR)
Number of subjects: 278

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 278
Study: 17332443

Group type: EXPERIMENTAL
Intervention: 40 mg pravastatin
Number of subjects: 355

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 355
Study: 15111338

Group type: EXPERIMENTAL
Intervention: Booklets
Number of subjects: 328

Group type: EXPERIMENTAL
Intervention: Videotapes
Number of subjects: 328

Group type: EXPERIMENTAL
Intervention: Information provided
Number of subjects: 328
Study: 11439376

Group type: EXPERIMENTAL
Intervention: Hand brace worn at night for 4 weeks
Number of subjects: 83

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 83
Study: 9704776

Group type: EXPERIMENTAL
Intervention: Cervical cerclage (n = 19)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Conservative management (n = 20)
Number of subjects: 39
Study: 8582132

Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) infusion at 24 mU kg‐1 min‐1
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) infusion at 12 mU kg‐1 min‐1
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) infusion at 6 mU kg‐1 min‐1
Number of subjects: 7

Group type: COMPARATOR
Intervention: Control (saline infusion)
Number of subjects: 7
Study: 1978069

Group type: EXPERIMENTAL
Intervention: Nimodipine 120 mg per day
Number of subjects: 1215

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1215
Study: 69882

Group type: EXPERIMENTAL
Intervention: Monoamine-oxidase inhibitors (clorgyline and pargyline)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 2
Study: 31407967

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy (NAC)
Number of subjects: 408

Group type: EXPERIMENTAL
Intervention: Clinical model using predictors (clinical stage N2 or N3, presence of axillary lymphadenopathy at US after NAC, tumor size reduction less than 50% at MRI, Ki‐67 negativity, hormone receptor positivity, and HER2 negativity)
Number of subjects: 408

Group type: EXPERIMENTAL
Intervention: Simplified risk score of 1
Number of subjects: 408
Study: 28237085

Group type: EXPERIMENTAL
Intervention: SQ-LNS (small-quantity lipid-based nutrient supplement)
Number of subjects: 2711

Group type: COMPARATOR
Intervention: Iron-folic acid
Number of subjects: 2711

Group type: COMPARATOR
Intervention: Multiple micronutrients
Number of subjects: 2711
Study: 26005768

Group type: EXPERIMENTAL
Intervention: Early Supported Discharge (ESD) in a day unit
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Early Supported Discharge (ESD) at home
Number of subjects: 154

Group type: COMPARATOR
Intervention: Traditional treatment in the municipality (control group)
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Early Supported Discharge (ESD) models
Number of subjects: 154
Study: 23690321

Group type: EXPERIMENTAL
Intervention: On-site facilitation and learning collaboratives
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 23
Study: 21559908

Group type: EXPERIMENTAL
Intervention: Micro-coaxial incision (2.2 mm)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Standard incision (2.8 mm)
Number of subjects: 76
Study: 19408007

Group type: EXPERIMENTAL
Intervention: 1.609-km walk at 1.34 m s(‐1)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: 1.609-km jog at 2.23 m s(‐1)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Both walking and jogging activities
Number of subjects: 26
Study: 17152005

Group type: EXPERIMENTAL
Intervention: SNPs in the IL‐2 gene (IVS1‐100G (rs2069762) and Ex2‐34G (rs2069763))
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: SNPs in the IL‐10 gene
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: SNPs in the IL‐12R genes
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: SNPs in the IL‐4RA and IL‐12B genes
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: SNPs
Number of subjects: 118
Study: 15163449

Group type: EXPERIMENTAL
Intervention: Word Memory Test (WMT)
Number of subjects: 519

Group type: COMPARATOR
Intervention: Test of Memory Malingering (TOMM)
Number of subjects: 519

Group type: COMPARATOR
Intervention: Computerized Assessment of Response Bias (CARB)
Number of subjects: 519
Study: 11447496

Group type: EXPERIMENTAL
Intervention: Ketanserin
Number of subjects: 102

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 102
Study: 9727709

Group type: EXPERIMENTAL
Intervention: IPPV (high rate 60‐80/min, low peak pressures)
Number of subjects: 76

Group type: COMPARATOR
Intervention: HFOV (aiming at optimization of lung volume)
Number of subjects: 76
Study: 7736902

Group type: EXPERIMENTAL
Intervention: Acarbose
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control (diet only or diet and sulphonylurea)
Number of subjects: 27
Study: 2341458

Group type: EXPERIMENTAL
Intervention: Phenol cauterisation
Number of subjects: 249

Group type: COMPARATOR
Intervention: Wedge excision
Number of subjects: 249
Study: 329848

Group type: EXPERIMENTAL
Intervention: Glycopyrrolate 0.2 mg + Neostigmine 1.0 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Atropine + Neostigmine (exact dosage not specified)
Number of subjects: 0
Study: 30948215

Group type: EXPERIMENTAL
Intervention: Whip-stitch (WS) technique
Number of subjects: 10

Group type: COMPARATOR
Intervention: Simple suture technique (SST)
Number of subjects: 10
Study: 27838943

Group type: EXPERIMENTAL
Intervention: Betamethasone (two consecutive doses of 12 mg intramuscularly, 24 hours apart)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (saline as a placebo)
Number of subjects: 40
Study: 25459995

Group type: COMPARATOR
Intervention: Probiotic strains (Bifidobacterium longum, B. lactis, Lactobacillus acidophilus, L. rhamnosus, L. plantarum, and Pediococcus pentosaceus) at a dose of 10^9 colony forming units/g, administered twice daily for 1 week.
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo, administered twice daily for 1 week.
Number of subjects: 29
Study: 23787721

Group type: EXPERIMENTAL
Intervention: Valsartan and an ACE inhibitor (dual RAAS blockade)
Number of subjects: 5010

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5010
Study: 16373275

Group type: EXPERIMENTAL
Intervention: Gluten-free diet (GFD)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Gluten-free diet supplemented with oats
Number of subjects: 116
Study: 16700140

Group type: EXPERIMENTAL
Intervention: Involuntary outpatient commitment (OPC) sustained for 6 months or longer
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Outpatient visits frequency
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sustained OPC beyond an initial court order
Number of subjects: 0
Study: 10100139

Group type: EXPERIMENTAL
Intervention: Multifetal pregnancy reduction
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 8659771

Group type: EXPERIMENTAL
Intervention: Intravenous tramadol (150 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Epidural morphine (2 mg bolus + 0.2 mg/h continuous infusion)
Number of subjects: 0
Study: 1517926

Group type: EXPERIMENTAL
Intervention: Cefpodoxime proxetil
Number of subjects: 229

Group type: COMPARATOR
Intervention: Amoxicillin-clavulanate
Number of subjects: 229
Study: 6824247

Group type: EXPERIMENTAL
Intervention: Tamoxifen and fluoxymesterone
Number of subjects: 108

Group type: COMPARATOR
Intervention: Tamoxifen alone
Number of subjects: 108
Study: 30389347

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy for insomnia (CBT-I) combined with the modern neuroscience approach
Number of subjects: 120

Group type: COMPARATOR
Intervention: Modern neuroscience approach alone
Number of subjects: 120
Study: 29171486

Group type: EXPERIMENTAL
Intervention: Cerebrolysin treatment
Number of subjects: 80
Study: 26595559

Group type: EXPERIMENTAL
Intervention: Abstinent heroin abusers (AHs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Healthy controls (HCs)
Number of subjects: 0
Study: 23273292

Group type: EXPERIMENTAL
Intervention: Serelaxin
Number of subjects: 1395

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1395
Study: 21696814

Group type: EXPERIMENTAL
Intervention: Partially hydrolyzed whey formula (pHWF)
Number of subjects: 620

Group type: EXPERIMENTAL
Intervention: Soy formula
Number of subjects: 620

Group type: COMPARATOR
Intervention: Conventional cow's milk formula
Number of subjects: 620
Study: 19155895

Group type: EXPERIMENTAL
Intervention: Oral sedation (10 mg of oxycodone and 1 mg of lorazepam)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Intravenous sedation (100 micrograms fentanyl and 2 mg midazolam)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Comparison of oral sedation to intravenous sedation
Number of subjects: 130

Group type: COMPARATOR
Intervention: Postoperative adverse effects
Number of subjects: 130
Study: 16565627

Group type: EXPERIMENTAL
Intervention: 8-week moderate-intensity aerobic exercise intervention
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 41
Study: 14556856

Group type: EXPERIMENTAL
Intervention: Serum ferritin concentration
Number of subjects: 669
Study: 10751205

Group type: EXPERIMENTAL
Intervention: Men who were lighter or shorter as babies
Number of subjects: 163

Group type: COMPARATOR
Intervention: Overall glucose tolerance
Number of subjects: 163

Group type: COMPARATOR
Intervention: Women
Number of subjects: 163
Study: 8617132

Group type: EXPERIMENTAL
Intervention: Cisapride 10 mg four times a day for three days
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 1418064

Group type: EXPERIMENTAL
Intervention: Crystalline lactulose (60 g/d for 30 days)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 20
Study: 6319087

Group type: EXPERIMENTAL
Intervention: Oral digoxin (0.25 mg/day)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 30930896

Group type: EXPERIMENTAL
Intervention: RTS,S vaccination
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparator
Number of subjects: 0
Study: 28590157

Group type: EXPERIMENTAL
Intervention: Focused narrative intervention in addition to usual care
Number of subjects: 57

Group type: COMPARATOR
Intervention: Usual care only
Number of subjects: 57
Study: 26988348

Group type: EXPERIMENTAL
Intervention: GDm‐health system and half the normal clinic visits
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal clinic care
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GDm‐health system
Number of subjects: 0
Study: 24766387

Group type: EXPERIMENTAL
Intervention: Nurse-led counselling programme (Healthy Skin Clinic)
Number of subjects: 306

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 306
Study: 22375947

Group type: EXPERIMENTAL
Intervention: Psychosocial counselling (5-8 sessions)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Routine medical treatment (treatment as usual)
Number of subjects: 61
Study: 19540054

Group type: EXPERIMENTAL
Intervention: Treatment plans meeting dose-volume constraints (V30<=80%, V40<=65%, V50<=55%, V60<=40%, V65<=30%, V70<=15%, V75<=3%)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 0
Study: 17535971

Group type: EXPERIMENTAL
Intervention: Modified vaccinia virus Ankara (MVA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dryvax
Number of subjects: 0
Study: 16123531

Group type: EXPERIMENTAL
Intervention: Standard intervention
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Standard plus family intervention
Number of subjects: 64

Group type: COMPARATOR
Intervention: Not available
Number of subjects: 64
Study: 12365829

Group type: EXPERIMENTAL
Intervention: Ancrod treatment
Number of subjects: 0
Study: 10426891

Group type: EXPERIMENTAL
Intervention: Doxepin/TAC cream (0.025% triamcinolone acetonide)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Doxepin cream (5% doxepin hydrochloride)
Number of subjects: 24
Study: 7547092

Group type: EXPERIMENTAL
Intervention: Tenidap sodium 120 mg day‐1
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 2158440

Group type: EXPERIMENTAL
Intervention: ZK 95962 (20 micrograms/kg body weight, 2 injections, 10 min apart)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo injections
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: ZK 95962
Number of subjects: 6
Study: 7363678

Group type: EXPERIMENTAL
Intervention: Triflo II
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Bartlett‐Edwards Incentive Spirometer
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Spirocare
Number of subjects: 79
Study: 31275980

Group type: EXPERIMENTAL
Intervention: HBOT
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study: 27129589

Group type: EXPERIMENTAL
Intervention: Herbal lollipops (C-1)
Number of subjects: 108
Study: 25858634

Group type: EXPERIMENTAL
Intervention: Brief health talk on cervical cancer
Number of subjects: 419

Group type: COMPARATOR
Intervention: Control group (no health talk)
Number of subjects: 419

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 419

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 419
Study: 24211163

Group type: EXPERIMENTAL
Intervention: Dasatinib (100 mg orally once daily) plus docetaxel (75 mg/m² intravenously every 3 weeks, plus oral prednisone 5 mg twice daily)
Number of subjects: 1522

Group type: COMPARATOR
Intervention: Placebo plus docetaxel (75 mg/m² intravenously every 3 weeks, plus oral prednisone 5 mg twice daily)
Number of subjects: 1522

Group type: EXPERIMENTAL
Intervention: Dasatinib (100 mg orally once daily) plus docetaxel
Number of subjects: 1522

Group type: COMPARATOR
Intervention: Placebo plus docetaxel
Number of subjects: 1522
Study: 21430254

Group type: EXPERIMENTAL
Intervention: 10 g of L-essential amino acids (EAA)
Number of subjects: 8

Group type: COMPARATOR
Intervention: rapamycin (mTORC1 inhibitor) prior to EAA ingestion
Number of subjects: 8
Study: 19646931

Group type: EXPERIMENTAL
Intervention: Carbamazepine withdrawal
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Valproate withdrawal in women
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control group (nonwithdrawal)
Number of subjects: 160
Study: 17287702

Group type: EXPERIMENTAL
Intervention: Nelson technique (as modified by Harris)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Langer technique
Number of subjects: 35
Study: 15522364

Group type: EXPERIMENTAL
Intervention: Surgical removal of blood and any associated CNV
Number of subjects: 336

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 336
Study: 16052904

Group type: EXPERIMENTAL
Intervention: DM+SE
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: DM+TC
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: DM+SE+TC
Number of subjects: 249

Group type: COMPARATOR
Intervention: DM
Number of subjects: 249
Study: 9213204

Group type: EXPERIMENTAL
Intervention: Saterinone
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 8353700

Group type: EXPERIMENTAL
Intervention: Experimental home‐based psychiatric service
Number of subjects: 172

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 172
Study: 3305036

Group type: EXPERIMENTAL
Intervention: Piroxicam
Number of subjects: 1004

Group type: COMPARATOR
Intervention: Indomethacin
Number of subjects: 1004

Group type: COMPARATOR
Intervention: Naproxen
Number of subjects: 1004